Search

Author/Creator Murthy, Rashmi

1. 53. TUCATINIB VS PLACEBO ADDED TO TRASTUZUMAB AND CAPECITABINE FOR PATIENTS WITH PREVIOUSLY TREATED HER2+ METASTATIC BREAST CANCER (MBC) WITH BRAIN METASTASES (BM) (HER2CLIMB). (4th August 2020)

Authors:
Lin, Nancy; Murthy, Rashmi; Anders, Carey; Borges, Virginia; Hurvitz, Sara; Loi, Sherene; Abramson, Vandana; Bedard, Philippe; Oliveira, Mafalda; Zelnack, Amelia; DiGiovanna, Michael; Bachelot, Thomas; Chien, A Jo; O'Regan, Ruth; Wardley, Andrew; Mueller, Volkmar; Carey, Lisa; McGoldrick, Suzanne...
Journal:
Neuro-oncology advances
Issue:
Volume 2(2020)Supplement 2
Page Start:
ii11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. CTNI-02. TBCRC049: A PHASE II STUDY TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF TUCATINIB, TRASTUZUMAB AND CAPECITABINE FOR THE TREATMENT OF LEPTOMENINGEAL METASTASIS IN HER2 POSITIVE BR1AST CANCER. (9th November 2020)

Authors:
Murthy, Rashmi; O'Brien, Barbara; Berry, Donald; Navin, Nicholas; Johnson, Jason; Gule-Monroe, Maria; Leone, Jose; Specht, Jennifer; Melisko, Michelle; Morikawa, Aki; Storniolo, Anna; Brufsky, Adam; Pohlmann, Paula; Park, Deric; Park, Ben; Krop, Ian; Lin, Nancy; Rimawi, Mothaffar; Wolff, Antonio;...
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii41
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Evaluation of surrogate measures of pulmonary function derived from electrical impedance tomography data in children with cystic fibrosis. (26th April 2018)

Authors:
Muller, Peter A; Mueller, Jennifer L; Mellenthin, Michelle; Murthy, Rashmi; Capps, Michael; Wagner, Brandie D; Alsaker, Melody; Deterding, Robin; Sagel, Scott D; Hoppe, Jordana
Journal:
Physiological measurement
Issue:
Volume 39:Number 4(2018:Apr.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study. Issue 7 (July 2018)

Authors:
Murthy, Rashmi; Borges, Virginia F; Conlin, Alison; Chaves, Jorge; Chamberlain, Marc; Gray, Todd; Vo, Alex; Hamilton, Erika
Journal:
Lancet oncology
Issue:
Volume 19:Issue 7(2018)
Page Start:
880
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗